Hohl Benjamin bought ELVN
September 17, 2026 · Form 4 insider transaction
Hohl Benjamin bought 3,982 shares of Enliven Therapeutics, Inc. at $14.85 per share, a transaction worth $59.1K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,982
Price
$14.85
Total value
$59.1K
InsiderHohl Benjamin
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 17, 2026
Filing dateSeptember 21, 2026
Shares owned after44,018
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026.; Certain of these securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock, subject to the applicable vesting schedule and conditions of each RSU.